NL-OMON46577已完成不适用
Plasmin generation in tPA-mediated fibrinolysis in patients with stroke - Plasmin generation in fibrinolysis for stroke
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Suffering from ischemic stroke
- •- Indicated treatment with tPA for thrombolysis
- •- Age > 18 years
排除标准
- •- Subject presents at the Gelre Hospital Apeldoorn with stroke but send to another hospital for mechanic thrombectomy (endovascular recanalization therapy)
- •- Stroke onset was more than 4.5 hours ago at the time of presentation at the Gelre Hospital. This precludes treatment with tPA, according to clinical practice guidelines, independent of the study protocol.
- •- Previously documented coagulation defects
- •- Age < 18 years
研究者
相似试验
已完成
不适用
Whole blood thrombin generation, platelet activation test and platelet-monocyte complex formation to predict hypercoagulability in patients with multiple myelomacancer of plasma cellsPlasma cell myeloma10018865NL-OMON48375Synapse Research Institute42
招募中
3 期
The role of anticoagulant and thrombolitic in treatment of COVID patientsCOVID 19.COVID-19, virus identifiedU07.1IRCT20200515047456N1Tabriz University of Medical Sciences15
尚未招募
不适用
Tissue Plasminogen Activator levels in Diabetic footCTRI/2020/07/026277AIIMS Bhubaneswar
已完成
1 期
Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic StrokeStrokeNCT00283088University of California, San Diego130
进行中（未招募）
1 期
A clinical trial of a clot dissolving drug and gas, injected into the eye, to treat bleeding associated with wet age-related macular degeneratioSub-macular haemorrhage secondary to wet macular degenerationMedDRA version: 16.0Level: PTClassification code 10064930Term: Age-related macular degenerationSystem Organ Class: 10015919 - Eye disordersMedDRA version: 16.0Level: LLTClassification code 10067791Term: Wet macular degenerationSystem Organ Class: 10015919 - Eye disordersEUCTR2012-004078-24-GBKing's College London